Acute Investment Advisory’s Apple AAPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$389K Sell
1,532
-3
-0.2% -$781 4.36% 11
2025
Q4
$417K Buy
1,535
+105
+7% +$28.2K 4.04% 6
2025
Q3
$364K Hold
1,430
3.06% 9
2025
Q2
$293K Buy
1,430
+10
+0.7% +$2.02K 2.39% 13
2025
Q1
$315K Sell
1,420
-6
-0.4% -$1.39K 1.59% 13
2024
Q4
$357K Sell
1,426
-222
-13% -$52.3K 0.39% 15
2024
Q3
$384K Hold
1,648
0.22% 12
2024
Q2
$347K Sell
1,648
-13
-0.8% -$2.42K 0.2% 11
2024
Q1
$285K Sell
1,661
-3,364
-67% -$612K 0.19% 8
2023
Q4
$967K Buy
5,025
+810
+19% +$150K 0.57% 9
2023
Q3
$722K Buy
4,215
+290
+7% +$53.2K 0.43% 9
2023
Q2
$761K Hold
3,925
0.46% 11
2023
Q1
$647K Buy
3,925
+56
+1% +$8.26K 0.42% 10
2022
Q4
$503K Sell
3,869
-7,463
-66% -$1.07M 0.34% 14
2022
Q3
$1.57M Hold
11,332
1.12% 18
2022
Q2
$1.55M Buy
11,332
+7,700
+212% +$1.17M 1.2% 19
2022
Q1
$634K Sell
3,632
-60
-2% -$10.1K 0.47% 30
2021
Q4
$656K Buy
+3,692
New +$583K 0.48% 39

Other funds holding AAPL

Acute Investment Advisory's AAPL Position: Q1 2026 in Review

Acute Investment Advisory reduced its Apple (AAPL) stake by 0.2% in Q1 2026, selling an estimated $781 and leaving 1,532 shares worth $389K. The position accounts for 4.36% of the portfolio, ranked #11.

Acute Investment Advisory first reported a position in AAPL in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.57M in Q3 2022. 6,073 funds tracked by Wall St. Rank hold AAPL as of Q1 2026.

  • Acute Investment Advisory held 1,532 shares of Apple worth $389K as of Q1 2026.
  • Acute Investment Advisory sold 3 Apple shares in Q1 2026, an estimated $781.
  • Apple made up 4.36% of Acute Investment Advisory's portfolio in Q1 2026, its #11 holding.
  • Acute Investment Advisory first reported a position in Apple in Q4 2021 and has held it in 18 quarters since.
  • Acute Investment Advisory's Apple position peaked at $1.57M in Q3 2022.
  • 6,073 funds tracked by Wall St. Rank held Apple as of Q1 2026.

Based on Acute Investment Advisory's 13F filing for Q1 2026, filed 27 Apr 2026.